miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 4039-4044

  Xiao, Zhong Di ^a,b   Jiao, Chun Yu ^b   Huang, Hai Tao ^b   He, Li Jia ^b   Zhao, Jiu Jun ^b   Lu, Zhao Yang ^a   Liu, Lian Xin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b Daqing Oilfield General Hospital   (China)

Author keywords

Hepatocellular carcinoma; HoxA10; miR 218; PTEN

Indexed keywords

HOMEODOMAIN PROTEIN; HOXA10 PROTEIN, MOUSE; MICRORNA; MIRN218 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PTEN PROTEIN, HUMAN;

CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84906256256     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. Int J Cancer 2010; 127: 2893-2917.
2. Rahbari NN, Mehrabi A, Mollberg NM, Muller SA, Koch M, Buchler MW and Weitz J. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 2011; 253: 453-469.
3. Worns MA and Galle PR. Future perspectives in hepatocellular carcinoma. Dig Liver Dis 2010; 42 Suppl 3: S302-309.
4. Vennarecci G, Santoro R, Antonini M, Ceribelli C, Laurenzi A, Moroni E, Burocchi M, Lepiane P and Ettorre GM. Liver transplantation for recurrent hepatic adenoma. World J Hepatol 2013; 5: 145-148.
5. Llovet JM, Schwartz M and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200.
6. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005; 15: 563-568.
7. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
8. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB and Bartel DP. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 2005; 310: 1817-1821.
9. Mallanna SK and Rizzino A. Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Dev Biol 2010; 344: 16-25.
10. Sun J, Lu H, Wang X and Jin H. MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. Scientific World Journal 2013; 2013: 924206.
11. Wong CM, Kai AK, Tsang FH and Ng IO. Regulation of hepatocarcinogenesis by microRNAs. Front Biosci 2013; 5: 49-60.
12. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP and Odenthal M. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008; 47: 1223-1232.
13. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR and Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
14. Gomez-Gomez Y, Organista-Nava J and Gariglio P. Deregulation of the miRNAs Expression in Cervical Cancer: Human Papillomavirus Implications. Biomed Res Int 2013; 2013: 407052.
15. Chen D, Cabay RJ, Jin Y, Wang A, Lu Y, Shah-Khan M and Zhou X. MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas. J Oral Maxillofac Res 2013; 4: e2.
16. Tian Y, Wong VW, Chan HL and Cheng AS. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. Semin Cancer Biol 2013; 23: 471-482.
17. Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K and Inazawa J. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 2011; 71: 5765-5778.